Back to search

Article

Real-world safety profile of Enfortumab Vedotin: A comprehensive pharmacovigilance analysis based on the FDA Adverse Event Reporting System (FAERS)

2026-06-09

Abstract excerpt

<h4>Background</h4> This study aimed to evaluate real-world adverse event (AE) signals of EV to provide evidence-based guidance for its safe clinical application. <h4>Methods</h4> Data from the FDA Adverse Event Reporting System (FAERS) database from the period of 2019 Q1–2025 Q3 were analyzed. Disproportionality analysis algorithms, including the reporting odds ratio (ROR), proportional reporting ratio (PRR), B...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c134ac28-0aae-54ce-918a-0223328f7f97
DOI
10.64898/2026.06.06.26355060
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Real-world safety profile of Enfortumab Vedotin: A comprehensive pharmacovigilance analysis based on the FDA Adverse Event Reporting System (FAERS)DOI 10.64898/2026.06.06.26355060
Select a neighboring publication to make it the new centre.